Answer Happy

Question 2: A Case of Parkinson's Disease. (25 points total) Your research team decided to test the effect of a novel molecular activator on dopamine expressing neuron cell survival in Parkinson's disease. In addition, your team also monitored levels of a novel transcription factor B mRNA levels in micromolar (UM) levels. 100 neurons were observed per group and condition. Evaluate the data below: Group Condition Average Percentage of Average transcription live neurons (%) factor B mRNA levels (UM) Normal dopamine No activator added 98% 50 M expressing neurons 45 UM Activator present at 50 85% UM Parkinson's disease No activator added 25% * affected dopamine expressing neurons 10 M Activator present at 50 75% UM 15 UM HA Note "+" shows statistically significant difference in experimental group compared to negative control group without activator. shows statistically significant different in experimental group with activator compared to no activator added in Parkinson's disease affected neurons. Part 2A: What conclusion(s) can we draw from the data above? Cite the results that support each conclusion(s). (10 points).